The firm is developing a drug called Survodutide that combats the MASH liver disease, which is tied to obesity
But the idea has merit, some researchers think, and that conclusion isnt based solely on anecdotes
Particularly when used alongside UV exposure
Acute Kidney Injury: Gastrointestinal side effects of compounded tirzepatide like diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems if dehydration is severe
The ideal candidates are individuals struggling with obesity or weight-related medical conditions who have not achieved weight loss through diet and exercise alone
Many patients experience improved insulin sensitivity, more stable blood sugar levels, and better metabolic markers across the board